Recombinant Human Activated Protein C in the Treatment of Acute Respiratory Distress Syndrome: A Randomized Clinical Trial

RATIONALE: Pulmonary coagulopathy may play a pathogenetic role in acute respiratory distress syndrome (ARDS), by contributing to alveolocapillary inflammation and increased permeability. Recombinant human activated protein C (rh-APC) may inhibit this process and thereby improve patient outcome. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Cornet, Alexander D., Groeneveld, A. B. Johan, Hofstra, Jorrit J., Vlaar, Alexander P., Tuinman, Pieter R., van Lingen, Arthur, Levi, Marcel, Girbes, Armand R. J., Schultz, Marcus J., Beishuizen, Albertus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954619/
https://www.ncbi.nlm.nih.gov/pubmed/24632673
http://dx.doi.org/10.1371/journal.pone.0090983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954619/
https://www.ncbi.nlm.nih.gov/pubmed/24632673
http://dx.doi.org/10.1371/journal.pone.0090983

Ejemplares similares